TherapeuticsMD News - TXMD

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
TherapeuticsMD Inc TXMD NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.07 -2.94% 2.31 2.44 2.30 2.40 2.38 00:00:03
more quote information »

Recent News

Date Time Source Heading
1/07/202006:30PRNUSTherapeuticsMD, An Innovative Women's Healthcare Company,..
1/06/202006:55BWTherapeuticsMD Announces Participation at the JP Morgan..
12/30/201907:03EDGARCurrent Report Filing (8-k)
12/30/201906:55BWTherapeuticsMD Announces Amendment to Term Loan Financing..
12/18/201917:28EDGARCurrent Report Filing (8-k)
12/10/201914:55EDGARAmended Statement of Ownership (sc 13g/a)
11/26/201907:30BWKnight and TherapeuticsMD Announce Filing of New Drug..
11/19/201906:48EDGARCurrent Report Filing (8-k)
11/12/201907:00BWTherapeuticsMD Announces Participation at the Stifel 2019..
11/08/201916:19EDGARQuarterly Report (10-q)
11/06/201916:11EDGARCurrent Report Filing (8-k)
11/06/201916:05BWTherapeuticsMD Announces Third Quarter 2019 Financial..
11/01/201916:05BWTherapeuticsMD to Report Third Quarter 2019 Results on..
10/30/201917:05BWKnight and TherapeuticsMD Announce Filing of New Drug..
10/29/201917:18EDGARStatement of Changes in Beneficial Ownership (4)
10/29/201917:17EDGARStatement of Changes in Beneficial Ownership (4)
10/29/201917:16EDGARStatement of Changes in Beneficial Ownership (4)
10/29/201916:05BWTherapeuticsMD Announces Closing of Its Underwritten Public..
10/29/201908:53EDGARCurrent Report Filing (8-k)
10/25/201916:48EDGARProspectus Filed Pursuant to Rule 424(b)(2) (424b2)
10/24/201919:46BWTherapeuticsMD Announces Pricing of Its Underwritten Public..
10/24/201906:03EDGARFree Writing Prospectus - Filing Under Securities Act Rules..
10/23/201917:25EDGARCurrent Report Filing (8-k)
10/23/201917:16EDGARFree Writing Prospectus - Filing Under Securities Act Rules..
10/23/201917:16EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
10/23/201916:45BWTherapeuticsMD Announces Proposed Underwritten Public..
10/23/201916:41BWTherapeuticsMD Announces Estimated Third Quarter 2019..
10/15/201907:03EDGARCurrent Report Filing (8-k)
10/11/201907:00BWTherapeuticsMD Announces Presentations on ANNOVERA™ at the..
10/10/201906:45BWTherapeuticsMD Vice President of Business Development Named..
10/01/201907:03EDGARCurrent Report Filing (8-k)
9/26/201907:00BWTherapeuticsMD Announces Participation at the 2019 Cantor..
9/25/201906:54EDGARCurrent Report Filing (8-k)
9/24/201907:00BWTherapeuticsMD Announces Multiple Presentations Related to..
9/16/201906:49EDGARCurrent Report Filing (8-k)
9/10/201915:27EDGARAmended Statement of Ownership (sc 13g/a)
8/26/201917:15EDGARStatement of Changes in Beneficial Ownership (4)
8/20/201917:13EDGARStatement of Changes in Beneficial Ownership (4)
8/19/201916:57EDGARStatement of Changes in Beneficial Ownership (4)
8/15/201916:34EDGARStatement of Changes in Beneficial Ownership (4)
8/14/201916:36EDGARStatement of Changes in Beneficial Ownership (4)
8/14/201916:34EDGARStatement of Changes in Beneficial Ownership (4)
8/13/201916:33EDGARStatement of Changes in Beneficial Ownership (4)
8/13/201916:32EDGARStatement of Changes in Beneficial Ownership (4)
8/12/201917:33EDGARStatement of Changes in Beneficial Ownership (4)
8/09/201915:01EDGARQuarterly Report (10-q)
8/06/201916:10EDGARCurrent Report Filing (8-k)
8/06/201916:05BWTherapeuticsMD Announces Second Quarter 2019 Financial..
7/25/201907:00BWTherapeuticsMD to Report Second Quarter 2019 Results on..
7/09/201906:59EDGARCurrent Report Filing (8-k)
See more news about this stock »


Your Recent History
NASDAQ
TXMD
Therapeuti..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.